New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Source: www.wired.com ·
Section: business-tech ·
Bias: Left
· Published: Sat, 24 Oct 2026 11:30:00 GMT
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Read the full article at www.wired.com →
← Back to FlashTopics.com